» Articles » PMID: 20679594

Lung Cancer Cell Lines As Tools for Biomedical Discovery and Research

Overview
Specialty Oncology
Date 2010 Aug 4
PMID 20679594
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer cell lines have made a substantial contribution to lung cancer translational research and biomedical discovery. A systematic approach to initiating and characterizing cell lines from small cell and non-small cell lung carcinomas has led to the current collection of more than 200 lung cancer cell lines, a number that exceeds those for other common epithelial cancers combined. The ready availability and widespread dissemination of the lines to investigators worldwide have resulted in more than 9000 citations, including multiple examples of important biomedical discoveries. The high (but not perfect) genomic similarities between lung cancer cell lines and the lung tumor type from which they were derived provide evidence of the relevance of their use. However, major problems including misidentification or cell line contamination remain. Ongoing studies and new approaches are expected to reveal the full potential of the lung cancer cell line panel.

Citing Articles

Preclinical Models for Functional Precision Lung Cancer Research.

Yu J, Kiss Z, Ma W, Liang R, Li T Cancers (Basel). 2025; 17(1.

PMID: 39796653 PMC: 11718887. DOI: 10.3390/cancers17010022.


Mutant RIT1 cooperates with YAP to drive an EMT-like lung cancer state.

Rominger M, Gupta S, Moorthi S, McSharry M, Kamlapurkar S, OBrien S bioRxiv. 2024; .

PMID: 39605726 PMC: 11601272. DOI: 10.1101/2024.11.11.623044.


CIGB-300 internalizes and impairs viability of NSCLC cells lacking actionable targets by inhibiting casein kinase-2 signaling.

Yi Y, Dai L, Lan Y, Tan C, Vazquez-Blomquist D, Zeng G Sci Rep. 2024; 14(1):26038.

PMID: 39472715 PMC: 11522547. DOI: 10.1038/s41598-024-75990-1.


Anticancer Activity of Imidazolyl Gold(I/III) Compounds in Non-Small Cell Lung Cancer Cell Lines.

Galassi R, Sargentoni N, Renzi S, Luciani L, Bartolacci C, Pattabhi P Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338298 PMC: 11435220. DOI: 10.3390/ph17091133.


TransCell: In Silico Characterization of Genomic Landscape and Cellular Responses by Deep Transfer Learning.

Yeh S, Paithankar S, Chen R, Xing J, Sun M, Liu K Genomics Proteomics Bioinformatics. 2024; 22(2).

PMID: 39240541 PMC: 11378636. DOI: 10.1093/gpbjnl/qzad008.


References
1.
Pleasance E, Cheetham R, Stephens P, McBride D, Humphray S, Greenman C . A comprehensive catalogue of somatic mutations from a human cancer genome. Nature. 2009; 463(7278):191-6. PMC: 3145108. DOI: 10.1038/nature08658. View

2.
Barnes D, van der Bosch J, Masui H, Miyazaki K, Sato G . The culture of human tumor cells in serum-free medium. Methods Enzymol. 1981; 79(Pt B):368-91. DOI: 10.1016/s0076-6879(81)79050-5. View

3.
Bottenstein J, Hayashi I, Hutchings S, Masui H, Mather J, McClure D . The growth of cells in serum-free hormone-supplemented media. Methods Enzymol. 1979; 58:94-109. DOI: 10.1016/s0076-6879(79)58127-0. View

4.
Gazdar A, Minna J . NCI series of cell lines: an historical perspective. J Cell Biochem Suppl. 1996; 24:1-11. DOI: 10.1002/jcb.240630502. View

5.
Singh A, Greninger P, Rhodes D, Koopman L, Violette S, Bardeesy N . A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. Cancer Cell. 2009; 15(6):489-500. PMC: 2743093. DOI: 10.1016/j.ccr.2009.03.022. View